1248 Management’s Medtronic MDT Stock Holding History

1248 Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.21K	Hold	94	–	–	﹤0.01%	138
2025 Q4	$9.1K	Hold	94	–	–	﹤0.01%	145
2025 Q3	$9.02K	Hold	94	–	–	0.01%	145
2025 Q2	$8.26K	Sell	94 -189	-67%	-$16K	﹤0.01%	160
2025 Q1	$25.6K	Buy	+283	New	+$25.3K	0.01%	139

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

1248 Management's MDT Position: Q1 2026 in Review

1248 Management held its Medtronic (MDT) position steady in Q1 2026 at 94 shares worth $8.21K. The position accounts for ﹤0.01% of the portfolio, ranked #138.

1248 Management first reported a position in MDT in Q1 2025 and has held it in 5 quarters since. The position peaked at $25.6K in Q1 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

1248 Management held 94 shares of Medtronic worth $8.21K as of Q1 2026.
1248 Management left its Medtronic share count unchanged in Q1 2026.
Medtronic made up ﹤0.01% of 1248 Management's portfolio in Q1 2026, its #138 holding.
1248 Management first reported a position in Medtronic in Q1 2025 and has held it in 5 quarters since.
1248 Management's Medtronic position peaked at $25.6K in Q1 2025.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on 1248 Management's 13F filing for Q1 2026, filed 15 May 2026.